Cardiol Therapeutics Inc. (CRDL) reporting calendar
Cardiol Therapeutics Inc. files periodic reports with the SEC as CRDL on Nasdaq. Atlas tracks 5 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 40-F
- Period ended
- 31 Dec 2025
- Filed
- 31 Mar 2026
- Reports on record
- 5
Open CRDL market profile
Latest filing on SEC EDGAR ↗
Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 40-F | 31 Dec 2025 | 31 Mar 2026 | 90 days | 0001104659-26-037844 |
| 40-F | 31 Dec 2024 | 31 Mar 2025 | 90 days | 0001410578-25-000588 |
| 20-F | 31 Dec 2023 | 1 Apr 2024 | 92 days | 0001104659-24-041952 |
| 20-F | 31 Dec 2022 | 29 Mar 2023 | 88 days | 0001104659-23-037820 |
| 40-F | 31 Dec 2021 | 24 Mar 2022 | 83 days | 0001104659-22-037207 |
Source: SEC EDGAR company submissions for CIK 0001702123. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.